Return to homepagePandemic Pact

Evaluation of nicotine as an ACE2 receptor inhibitor for prophylactic use in healthcare professionals and COVID19 contacts

  • Funded by Centro Regulador de Urgencias y Emergencias (CRUE Santander)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $79,800

  • Funder

    Centro Regulador de Urgencias y Emergencias (CRUE Santander)

  • Principal Investigator

    N/A

  • Research Location

    Spain

  • Lead Research Institution

    Universitat Internacional de Catalunya

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract